Clinical Trials Browser

Suspended × Interventional × Everolimus × Clear all

NCT03139747 2021-10-15

UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone

Phase 2 Suspended

Thyroid Neoplasms